Page last updated: 2024-10-26

dibucaine and HIV Coinfection

dibucaine has been researched along with HIV Coinfection in 1 studies

Dibucaine: A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)
cinchocaine : A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pankhurst, CL1
Lewis, DA1
Clark, DT1

Trials

1 trial available for dibucaine and HIV Coinfection

ArticleYear
Prophylactic application of an intra-alveolar socket medicament to reduce postextraction complications in HIV-seropositive patients.
    Oral surgery, oral medicine, and oral pathology, 1994, Volume: 77, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anesthetics, Local; Aspirin; Chlortetracycline; Dental Ca

1994